• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内测量年龄相关性白内障形成速率的策略。

Strategies for measuring the rate of age-related cataract formation in vivo.

作者信息

Chylack L T, Leske M C, Khu P, McCarthy D, Wu S Y

机构信息

Center for Clinical Cataract Research, Brigham and Women's Hospital.

出版信息

Lens Eye Toxic Res. 1989;6(4):515-22.

PMID:2487269
Abstract

The Lens Opacities Classification System (LOCS II) has been tested as a method for detecting and grading longitudinal changes in cataract severity. The LOCS I and II systems have already been tested and validated for cross-sectional classification of human cataracts in vivo. 130 eyes (of 68 patients) were photographed at baseline and follow-up visits with Neitz CTR and Zeiss slit photography. The mean length of follow-up was 14.7 +/- 4.4 months. The severity of nuclear opalescence (NO), cortical (C) and posterior subcapular cataract (P) was graded in a masked fashion using the LOCS II standards. Side-by-side comparisons of baseline and follow-up photos were also done in a masked fashion to detect more subtle changes than might be evident in the LOCS II gradings. The annual percent progression in cataracts graded by LOCS II standards are: (NO): 12.4%, (C): 17.9%, and (P): 6.5%. The LOCS II standards are offered as a promising subjective method for longitudinal grading of human cataractous change in vivo.

摘要

晶状体混浊分类系统(LOCS II)已作为一种检测和分级白内障严重程度纵向变化的方法进行了测试。LOCS I和II系统已在体内对人类白内障的横断面分类进行了测试和验证。对68例患者的130只眼睛在基线和随访时用Neitz CTR和蔡司裂隙摄影进行拍照。平均随访时间为14.7±4.4个月。使用LOCS II标准以盲法对核混浊(NO)、皮质(C)和后囊下白内障(P)的严重程度进行分级。还以盲法对基线和随访照片进行并排比较以检测比LOCS II分级中可能明显的更细微变化。按照LOCS II标准分级的白内障年进展百分比为:(NO):12.4%,(C):17.9%,(P):6.5%。LOCS II标准是一种很有前景的主观方法,用于体内人类白内障变化的纵向分级。

相似文献

1
Strategies for measuring the rate of age-related cataract formation in vivo.体内测量年龄相关性白内障形成速率的策略。
Lens Eye Toxic Res. 1989;6(4):515-22.
2
The effect of cataract severity and morphology on the reliability of the Lens Opacities Classification System II (LOCS II).白内障严重程度和形态对晶状体混浊分类系统II(LOCS II)可靠性的影响。
Invest Ophthalmol Vis Sci. 1991 Jul;32(8):2400-3.
3
A comparison of two photographic systems for grading cataract.两种用于白内障分级的摄影系统的比较。
Invest Ophthalmol Vis Sci. 1991 Mar;32(3):529-32.
4
Correlation of nuclear cataract lens density using Scheimpflug images with Lens Opacities Classification System III and visual function.使用Scheimpflug图像测量的核性白内障晶状体密度与晶状体混浊分类系统III及视觉功能的相关性。
Ophthalmology. 2009 Aug;116(8):1436-43. doi: 10.1016/j.ophtha.2009.03.002. Epub 2009 Jun 4.
5
Senile cataract progression studies using the Lens Opacities Classification System II.使用晶状体混浊分类系统II的老年性白内障进展研究。
Invest Ophthalmol Vis Sci. 1993 May;34(6):2138-41.
6
The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group.晶状体混浊分类系统III。白内障纵向研究组。
Arch Ophthalmol. 1993 Jun;111(6):831-6. doi: 10.1001/archopht.1993.01090060119035.
7
Lens Opacities Classification System.晶状体混浊分类系统
Arch Ophthalmol. 1988 Mar;106(3):330-4. doi: 10.1001/archopht.1988.01060130356020.
8
Comparison of methods to identify incident cataract in eyes of patients with neovascular maculopathy: Submacular Surgery Trials Report No. 18.新生血管性黄斑病变患者眼中识别初发性白内障方法的比较:黄斑下手术试验报告第18号。
Ophthalmology. 2008 Jan;115(1):127-33. doi: 10.1016/j.ophtha.2007.03.027. Epub 2007 Jun 14.
9
Influence of type and severity of pure forms of age-related cataract on visual acuity and contrast sensitivity. Italian American Cataract Study Group.年龄相关性白内障单纯类型及严重程度对视力和对比敏感度的影响。意大利裔美国人白内障研究组
Invest Ophthalmol Vis Sci. 1994 Jan;35(1):262-7.
10
Clinical application of a Scheimpflug system for lens density measurements in phacoemulsification.用于白内障超声乳化术中晶状体密度测量的Scheimpflug系统的临床应用
J Cataract Refract Surg. 2009 Jul;35(7):1204-9. doi: 10.1016/j.jcrs.2009.02.032.

引用本文的文献

1
Intravitreal triamcinolone with transpupillary therapy for subfoveal choroidal neovascularization in age related macular degeneration. A randomized controlled pilot study [ISRCTN74123635].
BMC Ophthalmol. 2005 Nov 25;5:27. doi: 10.1186/1471-2415-5-27.